Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) serves as an intermediate for synthesizing drug-linker conjugates in antibody-drug conjugates (ADCs). This compound is first conjugated to a polyamide through oxime bond formation, resulting in an MMAE polyamide conjugate. Subsequently, the MMAE polyamide conjugate is attached to Trastuzumab to create the ADC [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | (Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) serves as an intermediate for synthesizing drug-linker conjugates in antibody-drug conjugates (ADCs). This compound is first conjugated to a polyamide through oxime bond formation, resulting in an MMAE polyamide conjugate. Subsequently, the MMAE polyamide conjugate is attached to Trastuzumab to create the ADC [1]. |
Molecular Weight | 1196.48 |
Formula | C60H97N11O14 |
CAS No. | 2446645-88-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Aminooxy)acetamide-Val-Cit-PAB-MMAE 2446645-88-9 inhibitor inhibit